ROSS HARRISON enters MARIZYME, INC. with 175K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 1/13/2022ACC: 0001493152-22-001176
Officer· Vice President of Finance
Since Dec 2021
175K
Baseline shares
0.00
Direct ownership
0 positions
300K
Derivative underlying
2 instruments
1
Security positions
175K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned175K
Total
175K indirect175K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 175K | Indirect |
| Total | 175K | 175K indirect |
Derivative Holdings2
Consultant Stock Option (Right to Buy)
IndirectUnderlying security
Common Stock
Underlying shares
200K
Shares owned
N/A
Exercise price
1.75
Expiration
—
Exercise window
—
Warrants (Right to Buy)
IndirectUnderlying security
Common Stock
Underlying shares
100K
Shares owned
N/A
Exercise price
1.26
Expiration
—
Exercise window
—
Total
Underlying
300K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Consultant Stock Option (Right to Buy) Indirect | Common Stock | 1.75 | — | — | 200K | N/A |
| Warrants (Right to Buy) Indirect | Common Stock | 1.26 | — | — | 100K | N/A |
| Total | 300K | 0.00 | ||||